A detailed history of Panagora Asset Management Inc transactions in Insmed Inc stock. As of the latest transaction made, Panagora Asset Management Inc holds 290,470 shares of INSM stock, worth $19.3 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
290,470
Previous 356,135 18.44%
Holding current value
$19.3 Million
Previous $23.9 Million 11.14%
% of portfolio
0.1%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$62.0 - $79.01 $4.07 Million - $5.19 Million
-65,665 Reduced 18.44%
290,470 $21.2 Million
Q2 2024

Jul 29, 2024

SELL
$22.0 - $69.71 $3.49 Million - $11.1 Million
-158,694 Reduced 30.82%
356,135 $23.9 Million
Q1 2024

May 07, 2024

BUY
$25.72 - $29.94 $2.21 Million - $2.57 Million
85,826 Added 20.01%
514,829 $14 Million
Q4 2023

Feb 08, 2024

SELL
$23.42 - $31.74 $83,749 - $113,502
-3,576 Reduced 0.83%
429,003 $13.3 Million
Q3 2023

Oct 31, 2023

SELL
$19.86 - $26.93 $532,724 - $722,370
-26,824 Reduced 5.84%
432,579 $10.9 Million
Q2 2023

Aug 11, 2023

BUY
$16.44 - $21.1 $177,913 - $228,344
10,822 Added 2.41%
459,403 $9.69 Million
Q1 2023

May 11, 2023

BUY
$16.26 - $21.73 $566,856 - $757,551
34,862 Added 8.43%
448,581 $7.65 Million
Q4 2022

Feb 13, 2023

BUY
$16.98 - $23.15 $2.18 Million - $2.97 Million
128,161 Added 44.88%
413,719 $8.27 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $5.96 Million - $8.06 Million
285,558 New
285,558 $6.15 Million
Q2 2022

Aug 15, 2022

SELL
$17.07 - $25.71 $479,325 - $721,936
-28,080 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$20.42 - $28.13 $573,393 - $789,890
28,080 New
28,080 $660,000
Q3 2021

Nov 10, 2021

SELL
$22.46 - $29.47 $116,028 - $152,242
-5,166 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$24.17 - $36.01 $124,862 - $186,027
5,166 New
5,166 $147,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $8.98B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.